Current Neuro-Oncology
Volume
25 Number 10
31 May 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 10, 31 May
Maseko R, Mabogo M, Lockhat Z,
Makunyane P, Ahmad S, Bida M, Padayachy L.
Transorbital
neuroendoscopy-assisted resection of a giant optic pathway glioma
in a neonate.
Childs
Nerv Syst. 2023 May 16∟.
doi: 10.1007/s00381-023-05986-1∟.
PMID: 37191728∟.
Case report. ˍ
Movahed-Ezazi M, Nasir-Moin M, Fang
C, Pizzillo I, Galbraith K, Drexler S, Krasnozhen-Ratush OA,
Shroff S, Zagzag D, William C, Orringer D, Snuderl M.
Clinical
Validation of Stimulated Raman Histology for Rapid Intraoperative
Diagnosis of CNS Tumors.
Mod
Pathol. 2023 May 16:100219∟.
doi: 10.1016/j.modpat.2023.100219∟.
PMID: 37201685∟.
Observational study˰ ˍ
Jackson ER, Duchatel RJ, Staudt DE,
Persson ML, Mannan A, Yadavilli S, Parackal S, Game S, Chong WC,
Jayasekara WSN, Grand ML, Kearney PS, Douglas AM, Findlay IJ,
Germon ZP, McEwen HP, Beitaki TS, Patabendige A, Skerrett-Byrne
DA, Nixon B, Smith ND, Day B, Manoharan N, Nagabushan S, Hansford
JR, Govender D, McCowage GB, Firestein R, Howlett M, Endersby R,
Gottardo NG, Alvaro F, Waszak SM, Larsen MR, Colino-Sanguino Y,
Valdes-Mora F, Rakotomalala A, Meignan S, Pasquier E, André
N, Hulleman E, Eisenstat DD, Vitanza NA, Nazarian J, Koschmann C,
Mueller S, Cain JE, Dun MD.
ONC201
in Combination with Paxalisib for the Treatment of H3K27-Altered
Diffuse Midline Glioma.
Cancer
Res. 2023 May 17:OF1-OF17∟.
doi: 10.1158/0008-5472.CAN-23-0186∟.
PMID: 37195023∟.
Interventional study protocol. ˍ
Pouessel D, Ken S, Gouaze-Andersson
V, Piram L, Mervoyer A, Larrieu-Ciron D, Cabarrou B, Lusque A,
Robert M, Frenel JS, Uro-Coste E, Olivier P, Mounier M, Sabatini
U, Sanchez EH, Zouitine M, Berjaoui A, Cohen-Jonathan Moyal
E.
Hypofractionated
Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination
in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Oncologist.
2023 May 17:oyad095∟.
doi: 10.1093/oncolo/oyad095∟.
PMID: 37196069∟.
Interventional study. ˍ
Dentel A, Bremond-Gignac D, Robert
MP.
Intravitreal
Glioma in a Boy Aged 7 Years.
JAMA
Ophthalmol. 2023 May 18;141(5):e230083∟.
doi: 10.1001/jamaophthalmol.2023.0083∟.
PMID: 37199810∟.
Case report˰ ˍ
Kinslow CJ, Mercurio A, Kumar P,
Rae AI, Siegelin MD, Grinband J, Taparra K, Upadhyayula PS,
McKhann GM, Sisti MB, Bruce JN, Canoll PD, Iwamoto FM, Kachnic LA,
Yu JB, Cheng SK, Wang TJC.
Association
of MGMT Promotor Methylation With Survival in Low-grade and
Anaplastic Gliomas After Alkylating Chemotherapy.
JAMA
Oncol. 2023 May 18:e230990∟.
doi: 10.1001/jamaoncol.2023.0990∟.
PMID: 37200021∟.
Observational study˰ ˍ
Stritzelberger J, Gesmann A,
Fuhrmann I, Brandner S, Welte TM, Balk S, Eisenhut F, Dörfler
A, Coras R, Adler W, Schwab S, Putz F, Fietkau R, Distel L, Hamer
H.
Time
dependent risk factors for epileptic seizures in glioblastoma
patients: A retrospective analysis of 520 cases.
Epilepsia.
2023 May 18∟.
doi: 10.1111/epi.17658∟.
PMID: 37203264∟.
Observational study˰ ˍ
Dejonckheere CS, Thelen A, Simon B, Greschus S, Köksal MA,
Schmeel LC, Wilhelm-Buchstab T, Leitzen C.
Impact
of Postoperative Changes in Brain Anatomy on Target Volume
Delineation for High-Grade Glioma.
Cancers
(Basel). 2023 May 19;15(10):2840∟.
doi: 10.3390/cancers15102840∟.
PMID: 37345177∟.
Observational study. ˍ
Esparragosa Vazquez I, Ndiaye M, Di
Stefano AL, Younan N, Larrieu-Ciron D, Seyve A, Picart T, Meyronet
D, Boutet C, Vassal F, Carpentier C, Figarella-Branger D, Dehais
C, Forest F, Rivoirard R, Ducray F; POLA network.
FLAIR
pseudoprogression in patients with anaplastic oligodendrogliomas
treated with PCV chemotherapy alone.
Eur
J Neurol. 2023 May 19∟.
doi: 10.1111/ene.15873∟.
PMID: 37204066∟.
Observational study˰ ˍ
Ortega-Leonard LV, Del Río-Portilla
Y.
EEG
spectral power during REM sleep in patients with frontal brain
tumor.
BMC
Neurol. 2023 May 19;23(1):195∟.
doi: 10.1186/s12883-023-03243-1∟.
PMID: 37208614∟.
Observational study. ˍ
Ye L, Gu L, Zheng Z, Zhang X, Xing H, Guo X, Chen W, Wang Y, Wang
Y, Liang T, Wang H, Li Y, Jin S, Shi Y, Liu D, Yang T, Liu Q, Deng
C, Wang Y, Ma W.
An online survival
predictor in glioma patients using machine learning based on WHO
CNS5 data.
Front
Neurol. 2023 May 19;14:1179761∟.
doi: 10.3389/fneur.2023.1179761∟.
PMID: 37273702∟.
Observational study. ˍ
Constante M, Domingos J, Neves Coelho F, Baptista Fernandes T,
Baptista T, Maio Herculano M.
Strongyloides
stercoralis Dissemination and
Hyperinfection Associated with Long-Term Steroid Treatment in a
Neurosurgical Population.
Case
Rep Infect Dis. 2023 May 22;2023:4412935∟.
doi: 10.1155/2023/4412935∟.
PMID: 37261247∟.
Case report. ˍ
Minasi S, Gianno F, Bargiacchi L,
Barresi V, Miele E, Antonelli M, Buttarelli FR.
Case
report of a pediatric medulloblastoma with concurrent MYC and MYCN
subclonal amplification in distinct populations of neoplastic
cells.
Virchows
Arch. 2023 May 22∟.
doi: 10.1007/s00428-023-03560-3∟.
PMID: 37212894∟.
Case report˰ ˍ
Alimohamadi M, Pour-Rashidi A,
Digaleh H, Ajam Zibadi H, Hendi K, Raminfard S, Rahmani M,
Larijani A, Shirani M.
Disparity
of primary and secondary language outcomes in bilingual patients
undergoing resection of glioma of the speech-related
regions.
World
Neurosurg. 2023 May 23:S1878-8750(23)00693-9∟.
doi: 10.1016/j.wneu.2023.05.057∟.
PMID: 37230244∟.
Observational study˰ ˍ
Unnikrishnan S, Karunamuni R,
Salans MA, Gudipati S, Qian AS, Yu J, Connor M, Huynh-Le MP, Tibbs
MD, Hermann G, Reyes A, Stasenko A, Seibert TM, McDonald C,
Hattangadi-Gluth JA.
Dose-dependent
atrophy in bilateral amygdalae and nuclei after brain
radiotherapy: Association with mood and memory outcomes on a
longitudinal clinical trial.
Int
J Radiat Oncol Biol Phys. 2023 May 23∟.
doi: 10.1016/j.ijrobp.2023.05.026∟.
PMID: 37230430∟.
Interventional study˰ ˍ
Wang Y, Fushimi Y, Arakawa Y,
Shimizu Y, Sano K, Sakata A, Nakajima S, Okuchi S, Hinoda T,
Oshima S, Otani S, Ishimori T, Tanji M, Mineharu Y, Yoshida K,
Nakamoto Y.
Evaluation
of isocitrate dehydrogenase mutation in 2021 world health
organization classification grade 3 and 4 glioma adult-type
diffuse gliomas with 18F-fluoromisonidazole PET.
Jpn
J Radiol. 2023 May 23∟.
doi: 10.1007/s11604-023-01450-x∟.
PMID: 37219717∟.
Interventional study. ˍ
An J, Freeman E, Stewart IJ, Dore
M.
Association
of Traumatic Brain Injury and Glioblastoma Multiforme: A Case
Series.
Mil Med.
2023 May 24:usad162∟.
doi: 10.1093/milmed/usad162∟.
PMID: 37223958∟.
Case report. ˍ
Look T, Puca E, Bühler M,
Kirschenbaum D, De Luca R, Stucchi R, Ravazza D, Di Nitto C, Roth
P, Katzenelenbogen Y, Weiner A, Rindlisbacher L, Becher B, Amit I,
Weller M, Neri D, Hemmerle T, Weiss T.
Targeted
delivery of tumor necrosis factor in combination with CCNU induces
a T cell-dependent regression of glioblastoma.
Sci
Transl Med. 2023 May 24;15(697):eadf2281∟.
doi: 10.1126/scitranslmed.adf2281∟.
PMID: 37224228∟.
Laboratory investigation, Interventional study˰ ˍ
Moreno L, Teira P, Croop JM, Gerber NU, André N, Aerts I,
Gros Subias L, De Wilde B, Bautista F, Turpin B, Kunduri S, Hamidi
A, Lawrence T, Streby KA.
A phase 1,
first-in-child, multicenter study to evaluate the safety and
efficacy of the oncolytic herpes virus talimogene laherparepvec in
pediatric patients with advanced solid tumors.
Front
Pediatr. 2023 May 24;11:1183295∟.
doi: 10.3389/fped.2023.1183295∟.
PMID: 37292376∟.
Interventional study. ˍ
*
Kassubek R, Lulé D, Ludolph AC, Kassubek J, Müller
HP.
Bevacizumab is associated with
cerebral microstructural alterations: a DTI study in high-grade
glioma.
Front Neurol.
2023 May 25;14:1191226∟.
doi: 10.3389/fneur.2023.1191226∟.
PMID: 37305747∟.
Observational study. ˍ
Fareed A, Rohail S, Adnan A, Khan
AM.
DCvax:
A promising advancement in oncology for the treatment of
glioblastoma.
Rare
Tumors. 2023 May 26;15:20363613231179541∟.
doi: 10.1177/20363613231179541∟.
PMID: 37256198∟.
Letter. ˍ
REFERS
TO: A Phase III Clinical Trial Evaluating DCVax®-L, Autologous
Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment
Of Glioblastoma Multiforme (GBM).
Principal Investigator:
Linda Liau, M.D. University of California, Los Angeles.
Study
start date: December 2006. Estimated Primary Completion Date:
November 2022.
ClinicalTrials.gov Identifier:
NCT00045968∟.
Liau
LM, et al.: Association
of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With
Extension of Survival Among Patients With Newly Diagnosed and
Recurrent Glioblastoma: A Phase 3 Prospective Externally
Controlled Cohort Trial.
JAMA
Oncol. 2022 Nov 17∟.
doi: 10.1001/jamaoncol.2022.5370∟.
PMID: 36394838∟.
Interventional study. ˍ
Kazerooni AF, Khalili N, Liu X, Haldar D, Jiang Z, Anwar SM,
Albrecht J, Adewole M, Anazodo U, Anderson H, Bagheri S, Baid U,
Bergquist T, Calabrese E, Chung V, Conte GM, Dako F, Eddy J, Ezhov
I, Familiar A, Farahani K, Haldar S, Iglesias JE, Janas A,
Johansen E, Kofler F, LaBella D, Leemput KV, Li HB, Maleki N,
Meier Z, Menze B, Moawad AW, Piraud M, Poussaint T, Reitman Z,
Rudie JD, Shaikh IS, Shinohara RT, Tu W, Viswanathan K, Wang C,
Ware JB, Wiestler B, Wiggins W, Zapaishchykova A, Aboian M,
Bornhorst M, de Blank P, Deutsch M, Fouladi M, Hoffman L, Kann B,
Lazow M, Mikael L, Nabavizadeh A, Packer R, Resnick A, Rood B,
Vossough A, Bakas S, Linguraru MG.
The
Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on
Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs).
ArXiv
[Preprint]. 2023 May 26:arXiv:2305.17033v1∟.
PMID: 37292481∟.
Observational study. ˍ
Koessinger D, Novo D, Koessinger A, Campos A, Peters J, Dutton L,
Paschke P, Zerbst D, Moore M, Mitchell L, Neilson M, Stevenson K,
Chalmers A, Tait S, Birch J, Norman J.
Glioblastoma
extracellular vesicles influence glial cell hyaluronic acid
deposition to promote invasiveness.
Neurooncol
Adv. 2023 May 27;5(1):vdad067∟.
doi: 10.1093/noajnl/vdad067∟.
PMID: 37334166∟.
Laboratory investigation. ˍ
*
Kubelt C, Hellmold D, Esser D, Ahmeti H, Synowitz M, Held-Feindt
J.
Insights into Gene Regulation under
Temozolomide-Promoted Cellular Dormancy and Its Connection to
Stemness in Human Glioblastoma.
Cells.
2023 May 27;12(11):1491∟.
doi: 10.3390/cells12111491∟.
PMID: 37296610∟.
Laboratory investigation. ˍ
SEE
ALSO: Adamski V, et al., Dormant
glioblastoma cells acquire stem cell characteristics and are
differentially affected by Temozolomide and AT101 treatment.
Oncotarget.
2017 Nov 18;8(64):108064-108078∟.
doi: 10.18632/oncotarget.22514∟.
PMID:
29296224∟.
Laboratory investigation.
ˍ
Oraee-Yazdani S, Tavanaei R, Rostami F, Hajarizadeh A, Mehrabadi
M, Akhlaghpasand M, Tamaddon M, Khannejad S, Yazdani KO, Zali
A.
Suicide gene therapy using
allogeneic adipose tissue-derived mesenchymal stem cell gene
delivery vehicles in recurrent glioblastoma multiforme: a
first-in-human, dose-escalation, phase I clinical trial.
J
Transl Med. 2023 May 27;21(1):350∟.
doi: 10.1186/s12967-023-04213-4∟.
PMID: 37245011∟.
Interventional study. ˍ
Sirirungreung A, Hansen J, Ritz B,
Heck JE.
Association
between medically diagnosed postnatal infection and childhood
cancers: A matched case-control study in Denmark, 1978 to
2016.
Int J
Cancer. 2023 May 27∟.
doi: 10.1002/ijc.34604∟. PMID: 37243370∟.
Observational study. ˍ
Ohmura K, Ikegame Y, Yano H,
Shinoda J, Iwama T.
Methionine-PET
to differentiate between brain lesions appearing similar on
conventional CT/MRI scans.
J
Neuroimaging. 2023 May 28∟.
doi: 10.1111/jon.13126∟.
PMID: 37246342∟.
Observational study˰ ˍ
Piedade GS, Manoku E, Gelhardt AL, Cordeiro JG, Terzis
JA.
Atypical Presentation of a
Hemorrhagic Glioblastoma Multiforme Mimicking a Cerebral
Contusion.
Cureus.
2023 May 28;15(5):e39592∟.
doi: 10.7759/cureus.39592∟.
PMID: 37384093∟.
Case report. ˍ
Diaz M, Rana S, Silva Correia CE, Reiner AS, Lin AL, Miller AM,
Graham MS, Chudsky S, Bale TA, Rosenblum M, Karajannis MA,
Pentsova E.
Leptomeningeal disease in
histone-mutant gliomas.
Neurooncol
Adv. 2023 May 29;5(1):vdad068∟.
doi: 10.1093/noajnl/vdad068∟.
PMID: 37346983∟.
Observational study. ˍ
Eslin D, Zage PE, Bergendahl G,
Lewis E, Roberts W, Kraveka J, Mitchell D, Isakoff MS, Rawwas J,
Wada RK, Fluchel M, Brown VI, Ginn K, Higgins T,
BeeravallyNagulapally A, Dykema K, Hanna G, Ferguson W, Saulnier
Sholler GL.
A
phase II trial of nifurtimox combined with topotecan and
cyclophosphamide for refractory or relapsed neuroblastoma and
medulloblastoma.
Int
J Cancer. 2023 May 29∟.
doi: 10.1002/ijc.34569∟.
PMID: 37246577∟.
Interventional study. ˍ
Martucci M, Ferranti AM, Schimperna F, Infante A, Magnani F, Olivi
A, D'Alessandris QG, Gessi M, Chiesa S, Mazzarella C, Russo R,
Giordano C, Gaudino S.
Magnetic
resonance imaging-derived parameters to predict response to
regorafenib in recurrent glioblastoma.
Neuroradiology.
2023 May 29∟.
doi: 10.1007/s00234-023-03169-y∟.
PMID: 37247021∟.
Observational study˰ ˍ
McLaughlin LA, Yildirim O,
Rosenblum MK, Imber BS, Haseltine JM, Zelefsky MJ, Schöder H,
Morris MJ, Rafelson WM, Krebs S, Moss NS.
Identification
of incidental brain tumors in prostate cancer patients via PSMA
PET/CT.
J
Neurooncol. 2023 May 29∟.
doi: 10.1007/s11060-023-04355-x∟.
PMID: 37247180∟.
Observational study˰ ˍ
Zemskova O, Yu NY, Trillenberg P, Bonsanto MM, Leppert J, Rades
D.
Identification of Patients With
Glioblastoma Who May Benefit from Hypofractionated
Radiotherapy.
Anticancer
Res. 2023 May 29;43(6):2725-2732∟.
doi: 10.21873/anticanres.16439∟.
PMID: 37247904∟.
Observational study. ˍ
Bander ED, Kelly A, Ma X, Christos
PJ, Wernicke AG, Stieg PE, Trichter S, Knisely JPS, Ramakrishna R,
Schwartz TH.
Safety
and efficacy of Cesium-131 brachytherapy for brain tumors.
J
Neurooncol. 2023 May 30∟.
doi: 10.1007/s11060-023-04352-0∟.
PMID: 37249824∟.
Observational study˰ ˍ
*
Guberina N, Padeberg F, Pöttgen C, Guberina M, Lazaridis L,
Jabbarli R, Deuschl C, Herrmann K, Blau T, Wrede KH, Keyvani K,
Scheffler B, Hense J, Layer JP, Glas M, Sure U, Stuschke
M.
Location of Recurrences after
Trimodality Treatment for Glioblastoma with Respect to the
Delivered Radiation Dose Distribution and Its Influence on
Prognosis.
Cancers
(Basel). 2023 May 30;15(11):2982∟.
doi: 10.3390/cancers15112982∟.
PMID: 37296942∟.
Observational study. ˍ
Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L,
Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF,
Weller M, van den Bent M, Beck J, Hervey-Jumper S, Molinaro AM,
Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau
SJ, Chang SM, Berger MS, Esquenazi Y, Tonn JC.
Prognostic
evaluation of re-resection for recurrent glioblastoma using the
novel RANO classification for extent of resection: A report of the
RANO resect group.
Neuro
Oncol. 2023 May 30:noad074∟.
doi: 10.1093/neuonc/noad074∟.
PMID: 37253096∟.
Observational study. ˍ
Asl NS, Behfar M, Amiri RS, Mohseni R, Azimi M, Firouzi J,
Faranoush M, Izadpanah A, Mohmmad M, Hamidieh AA, Habibi Z,
Ebrahimi M.
Intra-lesion injection of
activated Natural Killer (NK) cells in recurrent malignant brain
tumors.
Int
Immunopharmacol. 2023 May 31;120:110345∟.
doi: 10.1016/j.intimp.2023.110345∟.
PMID: 37267858∟.
Observational study˰ ˍ
Moore-Palhares D, Chen H, Keith J,
Wang M, Myrehaug S, Tseng CL, Detsky J, Perry J, Lim-Fat MJ, Heyn
C, Maralani P, Lipsman N, Das S, Sahgal A, Soliman
H.
Re-irradiation
for recurrent high-grade glioma: an analysis of prognostic factors
for survival and predictors of radiation necrosis.
J
Neurooncol. 2023 May 31∟.
doi: 10.1007/s11060-023-04340-4∟.
PMID: 37256526∟.
Observational study˰ ˍ
Vize CJ, Kim SK, Matthews T, Macsai M, Merrell R, Hsu S, Kundu MG,
Yoon J, Kennedy E, Pai M, Bain E, Lassman AB, Moazami G.
A
Phase 3b Study for Management of Ocular Side Effects in Patients
with EGFR-Amplified Glioblastoma Receiving Depatuxizumab
Mafodotin.
Ophthalmic
Res. 2023 May 31∟.
doi: 10.1159/000531142? PMID: 37257422∟.
Interventional study. ˍ